Biocompatible Liposomes for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 15 September 2026 | Viewed by 1272
Special Issue Editors
Interests: nose-to-brain delivery; nanomedicine; albumin nanoparticles; polymeric micelles; freeze-drying
Special Issues, Collections and Topics in MDPI journals
Interests: liposomes; liposomal encapsulation; chlamydia; herpes viruses; sexually transmitted infections; drug delivery; antibiotic resistance
Special Issue Information
Dear Colleagues,
One of the greatest challenges facing modern medicine is the targeted, safe, and effective delivery of active ingredients into the body. In recent years, biocompatible liposomes—tiny spherical particles composed of naturally occurring phospholipids—have garnered enhanced attention in the field of drug delivery systems.
These nanoscopic “packaging” devices are capable of transporting both water-soluble and fat-soluble drug molecules. Their unique structure allows them to protect the active ingredient from degradation and deliver it directly to the desired cells or tissues, such as cancer cells or inflammatory areas. In addition, their potentiating effect in cases of infection is also significant.
Biocompatibility means that the components of liposomes do not trigger an immune response and do not harm the body during their degradation, making them ideal for long-term therapeutic use.
Current research is focused on developing liposome systems that are capable of
- increasing the stability and bioavailability of drugs,
- reducing side effects, and
- adapting to individual therapeutic needs.
This technology offers new opportunities not only in cancer therapy or the treatment of infections, but also in the drug therapy of inflammatory, autoimmune, or neurological diseases.
Biocompatible liposomes are therefore not just a laboratory curiosity, but represent a real opportunity to make the therapies of the future more personalized, effective, and safe.
This Special Issue of Pharmaceutics welcome the submission of reviews and original articles that demonstrate the use of biocompatible liposomes in various fields of medicine.
Dr. Katona Gábor
Dr. Anita Bogdanov
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposome
- biocompatible liposomes
- drug delivery system
- anti-cancer therapy
- anti-inflammatory therapy
- antibiotics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
